We explore how to refine and optimize care in the vital minutes following ROSC.
Hosts:
Jonathan Elmer, MD, MS
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Post-ROSC\_care.mp3 Download Leave a Comment Show Notes **Core EM Modular CME Course**Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below.
Course Highlights:
Click Here to Register and Begin Module 1
I. Phase 1: Stabilization (Minutes 0–10)The “Rearrest” Window & Pathophysiology High-Risk Period: Rearrest rates reach 30% within the first minutes post-ROSC. * Shock Incidence: Two-thirds of patients develop profound hypotension/shock as initial resuscitative efforts subside. * Catecholamine Washout: Super-physiologic “code-dose” epinephrine (1mg IV) typically wears off within ~3 minutes post-ROSC, leading to predictable hemodynamic collapse. * Secondary Injuries*: Evaluate for “CPR-induced trauma” (blunt thoracic trauma, rib fractures, pneumothorax, liver/splenic lacerations).
Immediate Resuscitative Actions Vascular Access: + Transition rapidly from IO to reliable IV access within 1–2 minutes. + Prioritize Intraosseous (IO) placement within 5 minutes if IV attempts fail; intra-arrest data suggests no significant difference in early outcomes. * Vasoactive “Bridge”: + Maintain a “bolus-dose” pressor at the bedside for immediate push-dose titration. + Options: Phenylephrine, dilute Epinephrine, or dilute Norepinephrine (titrated to effect rather than rigid dosing). * Physician-Specific Task: Arterial Line: + Goal: Placement within 5 minutes of ROSC. + Preferred Site: Femoral (by landmarks/blind if necessary) for speed; should be a <2-minute procedure. + Utility*: Immediate detection of rearrest and beat-to-beat titration of vasopressors.
II. Phase 2: Diagnostic Workup (Minutes 10–40)Etiology Epidemiology ACS Shift: Acute Coronary Syndrome (ACS) is the cause in only 6–10% of resuscitated survivors (lower than historical estimates). * Common Etiologies: * Respiratory*: COPD, pneumonia, mucus plugging.
+ **Cardiac**: Arrhythmia (cardiomyopathy/scar), RV failure (PE), or LV failure.
+ **Neurological**: Intracranial hemorrhage (SAH/ICH), status epilepticus (**4–5%**).
+ **Metabolic**: Dialysis-related disarray/hyperkalemia.
+ **Toxicology**: Overdose accounts for **~10%** of cases in urban centers.
The “Broad Net” Strategy “Rainbow Labs”: Comprehensive panel including toxicology and serial biomarkers. * Pan-Scan Protocol: + Components: CT/CTA Head/Neck, Contrast CT Chest/Abdomen/Pelvis. + Diagnostic Yield: 50% for clinically significant findings (causes or consequences of arrest). + Contrast Risk: Negligible (1–2% increase in AKI risk) compared to the high diagnostic utility. * Avoid Anchoring: Do not assume ischemic EKG changes are the cause; they are frequently a consequence* of the global arrest-induced ischemia.
III. Hemodynamic & Respiratory TargetsMean Arterial Pressure (MAP) Autoregulation Shift: In acute brain injury/post-arrest, the lower limit of cerebral autoregulation shifts right, often requiring MAPs of 110–120 mmHg for adequate perfusion. * Clinical Target: Aim for MAP >80 mmHg. * The BOX Trial Nuance*: While the BOX trial showed no difference between MAP 63 vs. 77, its cohort (Denmark) had exceptionally high survival rates (70% back to work) and short response times, which may not generalize to North American populations...